Board
Screen
Heat
Cal
Watch
News
Blog
TV
Home
/
ODTX
Home
/
ODTX

NASDAQ
$19.48
$19.48

Overview

Price performance
Low
$19.41
High
$22.36
Market open. Last updated: Nov 4, 2026, 8:09 PM UTC
$
19.48
-2.09 (-9.69%)
Average, 50 days
$21.58
$19.73
Open
$21.89
Previous close
$21.57
52-week high
$29.05
Sep 4, 2026 (3 months ago)
52-week low
$15.10
Jul 8, 2026 (4 months ago)
29.01%

Valuation & Estimates

Earnings

Financials

Insider Trading

Peer Analysis

Insights & Activity

Market Cap
936.18M
Volume
492 251
Total Return (3M)
-4.16%
Total Return (1Y)
16.50%
—
Sector
Healthcare
Links
Tags
Healthcare
Biotechnology
NASDAQ
US
Website
odysseytx.com
About
Odyssey Therapeutics, Inc. is a clinical-stage biopharmaceutical firm focused on discovering and developing novel treatments for autoimmune and inflammatory diseases. Its diverse pipeline features several key drug candidates: OD-001, an oral small molecule that inhibits receptor-interacting protein kinase 2, which is currently in Phase 2a clinical trials for ulcerative colitis. Also included is OD-002, an oral small molecule SLC15A4 inhibitor engineered to prevent harmful inflammatory responses driven by TLR7/8/9-mediated activation of interferon regulatory factor 5 (IRF5). Another program, OD-003, is a protein therapeutic designed to selectively agonize tumor necrosis factor receptor 2 on T regulatory cells. Further assets in its portfolio comprise a bispecific antagonist targeting TSLP and IL-33, an oral small molecule functioning as an interleukin-1 receptor-associated kinase 4 scaffolding inhibitor, and a separate small molecule inhibitor specifically targeting IRF5. The company was founded in 2021 and is headquartered in Boston, Massachusetts.

Frequently asked questions

ODTX · Odyssey Therapeutics, Inc.

01What is Odyssey Therapeutics, Inc. stock price today?

The current price of ODTX is $19.48 — it has decreased by 9.69% since the previous close. Data as of Nov 4, 2026.

02Is Odyssey Therapeutics, Inc. stock price growing?

ODTX is down 3.24% over the past week, down 7.72% over the past month and up 16.50% over the past year. The price is below its 200-day moving average of $19.73.

03What is Odyssey Therapeutics, Inc. market cap?

Odyssey Therapeutics, Inc. has a market capitalization of $936.18M. The company belongs to the Healthcare sector. Compare it with other companies in the stock screener.

04What were Odyssey Therapeutics, Inc. earnings last quarter?

In its most recent quarterly report, Odyssey Therapeutics, Inc. posted a loss of $1.74 per share against an estimate of -$1.61, missing expectations by 8.07%. Upcoming reports are listed in the earnings calendar.

05Who are Odyssey Therapeutics, Inc. competitors?

Companies most comparable to Odyssey Therapeutics, Inc. include Protagonist Therapeutics, Inc., Spyre Therapeutics, Inc., Oruka Therapeutics, Inc., AnaptysBio, Inc. and Alumis Inc.

06How volatile is ODTX stock?

In the latest trading session ODTX moved between $19.41 and $22.36, a range of 15.14% of its current price.

07What are ODTX stock 52-week high and low?

Over the past 52 weeks ODTX has traded between $15.10 and $29.05. The current price is 32.94% below its 52-week high.

Figures as of Nov 4, 2026. This information is provided for general purposes only and is not investment advice.